Grzegorz Kopeć

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension

Marius M. Hoeper, David B. Badesch, Hossein Ardeschir Ghofrani et al. · New England Journal of Medicine · 2023 · 557 citations · Full text

Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial

Roela Sadushi‐Kolici, Pavel Jansa, Grzegorz Kopeć et al. · The Lancet Respiratory Medicine · 2018 · 184 citations · Full text

Thrombosis, Pulmonary Embolism, Hypertension +9

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function

Iréne Lang, Asger Andersen, Hélène Bouvaist et al. · European Heart Journal · 2023 · 86 citations · Full text

Hypertension, Heart Failure, Adult Cardiac Surgery +25

Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial

Rogério Souza, David B. Badesch, Hossein Ardeschir Ghofrani et al. · European Respiratory Journal · 2023 · 79 citations · Full text

Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality

Anetta Undas, Marek Kolarz, Grzegorz Kopeć et al. · Nephrology Dialysis Transplantation · 2007 · 75 citations · Full text